Macquarie Group LTD Ionis Pharmaceuticals Inc Transaction History
Macquarie Group LTD
- $86.4 Billion
- Q4 2024
A detailed history of Macquarie Group LTD transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Macquarie Group LTD holds 1,769,743 shares of IONS stock, worth $59.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,769,743
Previous 1,869,806
5.35%
Holding current value
$59.7 Million
Previous $74.9 Million
17.4%
% of portfolio
0.07%
Previous 0.08%
Shares
26 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$556 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$478 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$387 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$348 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$293 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.79B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...